A Review of Safety, Efficacy, and Utilization of Erythropoietin, Darbepoetin, and Peginesatide for Patients with Cancer or Chronic Kidney Disease: A Report from the Southern Network on Adverse Reactions (SONAR)

The erythropoiesis-stimulating agents (ESAs) erythropoietin and darbepoetin prevent transfusions among chemotherapy-associated anemia patients. Clinical trials, meta-analyses, and guidelines identify mortality, tumor progression, and venous thromboembolism (VTE) risks with ESA administration in this...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Bennett, Charles L., Spiegel, David M., Macdougall, Iain C., Norris, LeAnn, Qureshi, Zaina P., Sartor, Oliver, Lai, Stephen Y., Tallman, Martin S., Raisch, Dennis W., Smith, Sheila Weiss, Silver, Samuel, Murday, Alanna S., Armitage, James O., Goldsmith, David
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3947540/
https://ncbi.nlm.nih.gov/pubmed/23111861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0032-1328884
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items